High-dose methotrexate: On the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL)

Cancer Chemotherapy and Pharmacology

Volumn 51, Issue 4, 2003, Pages 311-320

  Skarby T ^a   Jonsson P ^a   Hjorth, L ^a   Behrentz, M ^b   Bjork O ^c   Forestier, E ^d   Jarfelt, M ^e   Lonnerholm G ^f   Hoglund P ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Creatinine; Glomerular filtration rate; MTX elimination and renal function; Proximal tubule

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; CREATININE; CYSTATIN; FOLIC ACID ANTAGONIST; IMMUNOGLOBULIN G; IOHEXOL; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFANT; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 18744418618     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0552-1     Document Type: Article

References (29)

1. Abelson HT, Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, Link D (1983) Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol 1:208
2. Back SE, Masson P, Nilsson Ehle P (1988) A simple chemical method for the quantification of the contrast agent iohexol, applicable to glomerular filtration rate measurements. Scand J Clin Lab Invest 48:825
3. Bourke RS, Chheda G, Bremer A, Watanabe O, Tower DB (1975) Inhibition of renal tubular transport of methotrexate by probenecid. Cancer Res 35:110
4. Brandstrom E, Grzegorczyk A, Jacobsson L, Friberg P, Lindahl A, Aurell M (1998) GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 13:1176
5. Christensen ML, Rivera GK, Crom WR, Hancock ML, Evans WE (1988) Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia. J Clin Oncol 6:797
6. Deray G, Khayat D, Cacoub P, Bourbouze R, Musset L, Baumelou A, Jacquillat C, Jacobs C (1989) The effects of diltiazem on methotrexate-induced nephrotoxicity. Eur J Clin Pharmacol 37:337
7. Ferrari S, Orlandi M, Avella M, Caldora P, Ferraro A, Ravazzolo G, Bacci G (1992) Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate (in Italian). Minerva Med 83:289
8. Graf N, Winkler K, Betlemovic M, Fuchs N, Bode U (1994) Methotrexate pharmacokinetics and prognosis in osteosarcoma. J Clin Oncol 12:1443
9. Grubb A (1992) Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 38 [Suppl 1]:20
10. Gustafsson G, Kreuger A, Clausen N, Garwicz S, Kristinsson J, Lie SO, Moe PJ, Perkkio M, Yssing M, Saarinen-Pihkala UM (1998) Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatr 87:1151
11. Helin I, Axenram M, Grubb A (1998) Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol 49:221
12. Hjorth L, Helin I, Grubb A (2000) Age-related reference limits for urine levels of albumin, orosomucoid, immunoglobulin G and protein HC in children. Scand J Clin Lab Invest 60:65
13. Jacobs SA, Stoller RG, Chabner BA, Johns DG (1976) 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest 57:534
14. Jacobs SA, Stoller RG, Chabner BA, Johns DG (1977) Dose-dependent metabolism of methotrexate in man and rhesus monkeys. Cancer Treat Rep 61:651
15. Johnsson A, Hoglund P, Grubb A, Cavallin-Stahl E (1996) Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus. Cancer Chemother Pharmacol 39:25
16. Lawrenz-Wolf B, Wolfrom C, Frickel C, Fengler R, Wehinger H, Henze G (1994) Severe renal impairment of methotrexate elimination after high dose therapy (in German). Klin Padiatr 206:319
17. Murry DJ, Synold TW, Pui CH, Rodman JH (1995) Renal function and methotrexate clearance in children with newly diagnosed leukemia. Pharmacotherapy 15:144
18. Nilsson-Ehle P, Grubb A (1994) New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int Suppl 47:17
19. Pinedo HM, Chabner BA (1977) Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity. Cancer Treat Rep 61:709
20. Pinedo HM, Zaharko DS, Bull J, Chabner BA (1977) The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. Cancer Res 37:445
21. Rees H, Hann IM, Chessells JM, Webb DK (1999) Are glomerular filtration rate estimations necessary before high dose methotrexate? Arch Dis Child 81:339
22. Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui CH, Evans WE (1994) Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 12:1667
23. Ries F, Klastersky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8:368
24. Saeter G, Alvegard TA, Elomaa I, Stenwig AE, Holmstrom T, Solheim OP (1991) Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study. J Clin Oncol 9:1766
25. Sand TE, Jacobsen S (1981) Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol 19:453
26. Smeland E, Bremnes RM, Andersen A, Jaeger R, Eide TJ, Huseby NE, Aarbakke J (1994) Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat. Cancer Chemother Pharmacol 34:119
27. Tenter J, Thysell H, Andersson K, Grubb A (1994) Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. Stand J Clin Lab Invest 54:199
28. Tencer J, Thysell H, Grubb A (1996) Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Stand J Clin Lab Invest 56:691
29. Wolfrom C, Hartmann R, Fengler R, Bruhmuller S, Ingwersen A, Henze G (1993) Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 11:827